轻微肝性脑病丘脑代谢紊乱及其与区域神经功能异常和认知障碍的关联
本研究纳入38例肝硬化患者(18例轻微肝性脑病、20例无肝性脑病)和21名健康对照,采用氢质子磁共振波谱、静息态功能磁共振及心理肝性脑病评分进行评估。结果显示轻微肝性脑病患者丘脑谷氨酸复合物/肌酸升高、胆碱/肌酸和肌醇/肌酸降低,且这些代谢改变与特定频段低频波动振幅及认知评分相关;胆碱/肌酸和肌醇/肌酸对区分有无轻微肝性脑病具有中等判别能力,丘脑磁共振波谱可能作为诊断轻微肝性脑病的潜在生物标志物。
要点
- 轻微肝性脑病患者丘脑谷氨酸复合物/肌酸升高,胆碱/肌酸和肌醇/肌酸降低。
- 上述代谢改变从无肝性脑病到轻微肝性脑病呈加重趋势。
- 胆碱/肌酸和肌醇/肌酸与0.01-0.027 Hz频段低频波动振幅及心理肝性脑病评分正相关。
关键影像表现/征象
- 与健康对照相比,轻微肝性脑病患者丘脑谷氨酸复合物/肌酸升高,胆碱/肌酸和肌醇/肌酸降低。
- 这些代谢改变从无肝性脑病到轻微肝性脑病呈加重趋势。
- 胆碱/肌酸和肌醇/肌酸与0.01-0.027 Hz频段区域低频波动振幅及心理肝性脑病评分呈正相关。
诊断标准与关键数值
- 受试者工作特征曲线分析显示,胆碱/肌酸和肌醇/肌酸测量对区分无肝性脑病与轻微肝性脑病具有中等判别能力。
临床应用与阅片要点
- 丘脑磁共振波谱测量可能作为肝硬化患者中诊断轻微肝性脑病的潜在生物标志物。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To conduct the first investigation on thalamic metabolic alterations in minimal hepatic encephalopathy (MHE) and elucidate their association with intrinsic neural activity change and cognitive dysfunction.
METHODS: Thirty-eight cirrhotic patients [18 with MHE, 20 without MHE (NHE)] and 21 healthy controls (HC) were included, all of whom underwent 1H-magnetic resonance spectroscopy, resting-state functional magnetic resonance imaging (fMRI), as well as cognitive assessment based on the Psychometric Hepatic Encephalopathy Score (PHES). Metabolite ratios in the thalamus were measured, including N-acetyl aspartate (NAA)/creatine (Cr), glutamate plus glutamine (Glx)/Cr, choline (Cho)/Cr, and myo-inositol (mI)/Cr. Intrinsic neural activity was evaluated based on frequency-specific amplitude of low-frequency fluctuations (ALFF) using fMRI signals.
RESULTS: MHE patients showed an increase in Glx/Cr and a decrease in Cho/Cr and mI/Cr, compared with HC. These changes were aggravated from NHE to MHE. Cho/Cr and mI/Cr were positively correlated with regional ALFF derived from the frequency-specific band (0.01-0.027 Hz) and PHES. Receiver operating characteristic curve analysis showed that Cho/Cr and mI/Cr measurements exhibited moderate discrimination ability between NHE and MHE.
CONCLUSION: Our findings provide evidence that MHE is associated with disturbed metabolism in the thalamus, which may contribute to the altered neural activity and underlie the mechanisms of cognitive impairments. MRS measurements in the thalamus could serve as the potential biomarker for diagnosing MHE among cirrhotic patients.
引用
- Chen LH, Shi JY, Zou TX, et al. Disturbance of thalamic metabolism and its association with regional neural dysfunction and cognitive impairment in minimal hepatic encephalopathy. Eur J Radiol. 2020. PMID: 32949859. doi:10.1016/j.ejrad.2020.109252
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。